<DOC>
	<DOCNO>NCT01321333</DOCNO>
	<brief_summary>This study evaluate effect single transplantation HuCNS-SC cell thoracic spinal cord patient sub-acute spinal cord injury .</brief_summary>
	<brief_title>Study Human Central Nervous System Stem Cells ( HuCNS-SC ) Patients With Thoracic Spinal Cord Injury</brief_title>
	<detailed_description>Study subject receive immunosuppression nine month follow transplantation . All enrol subject follow one year follow transplantation enrol separate long-term follow-up study additional four year .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Thoracic Injuries</mesh_term>
	<criteria>T2T11 thoracic spinal cord injury base American Spinal Injury Association ( ASIA ) level determination principal investigator ( PI ) T2T11 thoracic spinal cord injury assess magnetic resonance imaging ( MRI ) and/or computerize tomography ( CT ) ASIA Impairment Scale ( AIS ) Grade A , B , C Minimum six week post injury initiation screening Must evidence preserve conus function Must stable stage medical recovery injury History traumatic brain injury without recovery Penetrating spinal cord injury Evidence spinal instability persistent spinal stenosis and/or compression relate initial trauma Previous organ , tissue bone marrow transplantation Previous participation gene transfer cell transplant trial Current prior malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>thoracic spinal cord injury</keyword>
	<keyword>spinal cord injury thoracic</keyword>
	<keyword>sub-acute spinal cord injury</keyword>
	<keyword>human neural stem cell</keyword>
	<keyword>stem cell</keyword>
	<keyword>stem cell transplant</keyword>
	<keyword>stem cell transplant spinal cord injury</keyword>
</DOC>